KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Novavax (NVAX) Asset Utilization Ratio: 2009-2025

Historic Asset Utilization Ratio for Novavax (NVAX) over the last 16 years, with Sep 2025 value amounting to 0.80.

  • Novavax's Asset Utilization Ratio rose 58.59% to 0.80 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.80, marking a year-over-year increase of 58.59%. This contributed to the annual value of 0.41 for FY2024, which is 16.23% down from last year.
  • As of Q3 2025, Novavax's Asset Utilization Ratio stood at 0.80, which was up 3.05% from 0.77 recorded in Q2 2025.
  • Over the past 5 years, Novavax's Asset Utilization Ratio peaked at 0.99 during Q2 2023, and registered a low of 0.42 during Q4 2024.
  • Its 3-year average for Asset Utilization Ratio is 0.68, with a median of 0.63 in 2024.
  • Per our database at Business Quant, Novavax's Asset Utilization Ratio spiked by 508.75% in 2021 and then plummeted by 37.09% in 2024.
  • Quarterly analysis of 5 years shows Novavax's Asset Utilization Ratio stood at 0.45 in 2021, then skyrocketed by 96.45% to 0.88 in 2022, then tumbled by 34.97% to 0.57 in 2023, then dropped by 26.80% to 0.42 in 2024, then surged by 58.59% to 0.80 in 2025.
  • Its last three reported values are 0.80 in Q3 2025, 0.77 for Q2 2025, and 0.88 during Q1 2025.